Preparation of PLGA nanoparticles using TPGS in the spontaneous emulsification solvent diffusion method

被引:32
作者
Esmaeili, Farnaz
Atyabi, Fatemeh
Dinarvand, Rassoul
机构
[1] Univ Tehran, Fac Pharm, Novel Drug Delivery Syst Lab, Tehran, Iran
[2] Univ Tehran, Med Nanotechnol Res Ctr, Tehran, Iran
关键词
TPGS; nanoparticles; spontaneous emulsification solvent diffusion; rifampicin; estradiol valerate;
D O I
10.1080/17458080701393137
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
D-alpha-tocopheryl poly (ethylene glycol) 1000 succinate (TPGS) is a widely used form of vitamin E that has been used as a solubilizer, an emulsifier and as a vehicle for drug delivery formulations. In this study, poly lactide-co-glycolide (PLGA) nanoparticles were prepared by spontaneous emulsification solvent diffusion (SESD) method. TPGS as an emulsifier and further as a matrix material blended with PLGA was used to enhance the encapsulation efficiency and improve the drug release profile of nanoparticles. Rifampicin and estradiol valerate were used as model drugs with different water solubility. The effect of formulation parameters such as drug/polymer ratio, oil phase combination, volume and surfactant content was evaluated. The surface morphology and size of the nanoparticles were studied by scanning electron microscopy (SEM) and laser light scattering. Drug encapsulation efficiency and in vitro drug release profiles of nanoparticles were determined using high performance liquid chromatography (HPLC). The nanoparticles prepared in this study were spherical with size range of 150-250 nm. It was shown that TPGS was a good emulsifier for producing nanoparticles of hydrophobic drugs and improving the encapsulation efficiency and drug loading and drug release profile of nanoparticles. However, the drug loading efficiency of rifampicin, a slightly water-soluble molecule, was significantly lower than that of estradiol valerate, a water insoluble molecule.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 13 条
[1]   RIFAMPICIN-CARRYING POLY(D,L-LACTIDE) MICROSPHERES - LOADING AND RELEASE [J].
DENKBAS, EB ;
KAITIAN, X ;
TUNCEL, A ;
PISKIN, E .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1995, 6 (09) :815-825
[2]   Polymeric nanospheres fabricated with natural emulsifiers for clinical administration of an anticancer drug paclitaxel (Taxol®) [J].
Feng, SS ;
Mu, L ;
Chen, BH ;
Pack, D .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 2002, 20 (1-2) :85-92
[3]   Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers [J].
Feng, SS ;
Huang, GF .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (01) :53-69
[4]   THE PREPARATION AND CHARACTERIZATION OF POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES .1. OIL-IN-WATER EMULSION SOLVENT EVAPORATION [J].
JEFFERY, H ;
DAVIS, SS ;
OHAGAN, DT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 77 (2-3) :169-175
[5]   A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®):: PLGA nanoparticles containing vitamin E TPGS [J].
Mu, L ;
Feng, SS .
JOURNAL OF CONTROLLED RELEASE, 2003, 86 (01) :33-48
[6]   α-tocopheryl succinate epitomizes a compound with a shift in biological activity due to pro-vitamin-to-vitamin conversion [J].
Neuzil, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 293 (05) :1309-1313
[7]   IN-VITRO DRUG-RELEASE BEHAVIOR OF D,L-LACTIDE/GLYCOLIDE COPOLYMER (PLGA) NANOSPHERES WITH NAFARELIN ACETATE PREPARED BY A NOVEL SPONTANEOUS EMULSIFICATION SOLVENT DIFFUSION METHOD [J].
NIWA, T ;
TAKEUCHI, H ;
HINO, T ;
KUNOU, N ;
KAWASHIMA, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (05) :727-732
[8]  
PARK K, 1997, CONTROLLED DRUG DELI, P529
[9]   Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique [J].
QuintanarGuerrero, D ;
Fessi, H ;
Allemann, E ;
Doelker, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 143 (02) :133-141
[10]   Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation [J].
Ricci, M ;
Blasi, P ;
Giovagnoli, S ;
Perioli, L ;
Vescovi, C ;
Rossi, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 275 (1-2) :61-72